GNA13 promotes brain metastasis of non-small cell lung cancer and EMT through the WNT/β catenin signaling pathway
Frontiers in Cell and Developmental Biology · 26.09.2025 · 13
DOI: 10.3389/fcell.2025.1652200 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cell and Developmental Biology, online erschienen am 26.09.2025. Verfasst von Jia-Qi Wu und 6 weiteren Autor:innen. Beteiligte Einrichtung: College of Biotechnology and Pharmaceutical Engineering, Nanjing Tech University, Nanjing, China. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Brain metastasis (BM) remains a major challenge in non-small cell lung cancer (NSCLC) treatment, with poorly understood mechanisms.
Methods
A zebrafish xenograft model was established using the H1299 cell line to study NSCLC BM. RNA-Seq identified differentially expressed genes (DEGs) in metastasized to brain vs. non-metastasized cells. Clinical relevance of DEGs was validated using The Cancer Genome Atlas (TCGA) and Kaplan-Meier survival analysis. The anti-proliferation, migration, and invasion effects of GNA13 were also detected using CCK8 assay, scratch wound healing assay, and transwell assay in vitro . The in vivo effects of GNA13 in proliferation and migration were further examined in zebrafish embryos. Additionally, real-time quantitative PCR (RT-qPCR) and Western Blot were performed to validate and explore the underlying molecular mechanisms.
Results
Through comprehensive RNA-Seq analysis of zebrafish xenograft model, we identified 177 DEGs significantly associated with NSCLC BM. KEGG and GO enrichment identified GNA13 as a key mediator in NSCLC BM. Clinical correlation analysis confirmed that GNA13 expression was associated with NSCLC BM and poor prognosis in lung cancer patients. Functional validation revealed that GNA13 knockdown reduced H1299 cell viability, migration, and invasion, whereas overexpression in A549 cells increased viability migration, and invasion in vitro . These in vitro findings were further validated in vivo , where GNA13 overexpression promoted tumor proliferation and metastatic potential. GNA13 was shown to activate the Wnt/β-catenin signaling pathway and induce epithelial-mesenchymal transition (EMT), thereby enhancing the metastatic potential of lung cancer cells.
Conclusion
This study identifies GNA13 as a key gene of lung cancer BM. GNA13 promotes EMT and enhances the proliferation and metastatic capacity of lung cancer cells by activating the Wnt/β-catenin signaling pathway. These findings suggest that GNA13 may serve as a potential therapeutic target for preventing or treating BM in NSCLC.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- College of Biotechnology and Pharmaceutical Engineering, Nanjing Tech University, Nanjing, China.
- Department of Science and Technology, The Affiliated Cancer Hospital of Nanjing Medical University and Jiangsu Cancer Hospital and Jiangsu Institute of Cancer Research, Nanjing, China.
Zitieren
APA
Wu, J. Q., Zou, H. P., Fan, R. Y., Cai, J., Wei, P., He, M. F., & Xiang, J. (2025). GNA13 promotes brain metastasis of non-small cell lung cancer and EMT through the WNT/β catenin signaling pathway. Frontiers in Cell and Developmental Biology, 13. https://doi.org/10.3389/fcell.2025.1652200
Vancouver
Wu JQ, Zou HP, Fan RY, Cai J, Wei P, He MF, et al. GNA13 promotes brain metastasis of non-small cell lung cancer and EMT through the WNT/β catenin signaling pathway. Frontiers in Cell and Developmental Biology. 2025;13. doi:10.3389/fcell.2025.1652200
BibTeX
@article{Wu2025,
author = {Wu, Jia-Qi and Zou, Han-Peng and Fan, Ruo-Yue and Cai, Jing and Wei, Ping and He, Ming-Fang and Xiang, Jin},
title = {GNA13 promotes brain metastasis of non-small cell lung cancer and EMT through the WNT/β catenin signaling pathway},
journal = {Frontiers in Cell and Developmental Biology},
year = {2025},
volume = {13},
doi = {10.3389/fcell.2025.1652200}
}
EUVIMED